Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies
Oncolytic viruses (OVs) represent a new class of cancer immunotherapeutics. Administration
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
[引用][C] Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
S Gujar, JG Pol, Y Kim, PW Lee, G Kroemer - Trends in Immunology, 2018 - cir.nii.ac.jp
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic
Virotherapies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Virotherapies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
S Gujar, JG Pol, Y Kim, PW Lee… - Trends in …, 2018 - pubmed.ncbi.nlm.nih.gov
Oncolytic viruses (OVs) represent a new class of cancer immunotherapeutics. Administration
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.
S Gujar, JG Pol, Y Kim, PW Lee, G Kroemer - Trends in Immunology, 2017 - europepmc.org
Oncolytic viruses (OVs) represent a new class of cancer immunotherapeutics. Administration
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
S Gujar, G Kroemer - Trends in immunology, 2018 - dialnet.unirioja.es
Oncolytic viruses (OVs) represent a new class of cancer immunotherapeutics. Administration
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
of OVs to cancer-bearing hosts induces two distinct immunities: antiviral and antitumor …
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
S Gujar, JG Pol, Y Kim, PW Lee, G Kroemer - Trends in Immunology, 2018 - Elsevier
HighlightsOVs can preferentially infect and kill malignant cancer cells, without imparting
similar lytic effects on normal cells.In addition to their direct oncolytic activity, OVs can …
similar lytic effects on normal cells.In addition to their direct oncolytic activity, OVs can …